Loading...

INDOCO Indoco Remedies Ltd Product Launches Announcement

ndc

NDC

Indoco Remedies Ltd

(INDOCO)

2024 Announcement

Show Summary

Show Summary

Share Transfer Notice

GST Notice Received

GST Proceedings Dropped

Investor Meeting

GST Proceedings Dropped

Annual Compliance Report

Earnings Call Transcript

Financial Results Published

Investor Meet Announced

Earnings Call Update

Auditor Appointments

Directorate Changes

Earnings Conference Call

Earnings Call Scheduled

Compliance Certificate

Tax Assessment Order

Code of Conduct Update

Cost Auditor Appointment

FDA Inspection Passed

Revised GST Order

GST Order Update

GST Order Update

GST Order Dropped

Show Cause Notice

Show Cause Notice

Dropped Proceedings

Credit Rating Change

Earnings Call Transcript

Financial Results Published

Earnings Call Audio

Earnings Call Announcement

Earnings Call Scheduled

Name Change RTA

Compliance Certificate

USFDA Warning Letter

Investor Meet Scheduled

Investor Meet Scheduled

GST Show Cause Notice

New Partnership

Analyst Meet Announced

Investor Meeting Scheduled

Investor Meeting

Management Appointment

FDA Approval Announcement

GST Show Cause Notice

Earnings Call Summary

Financial Results

Earnings Call Recording

Investor Presentation

Earnings Call Announcement

USFDA Status Update

Compliance Confirmation

FDA Approval Received

Investor Conference Notice

Investor Conference

AGM Announcement

Investor Conference Scheduled

AGM and Dividend

GST Notice Withdrawn

GST Demand Notice

Show Cause Notice Withdrawn

USFDA Observations

Disclosure on GST Notice

Earnings Call Transcript

GST Appeal Rejection

Earnings Conference Call Ou...

Financial Results Publication

Compliance Certificate Subm...

GST Demand Notice

Disclosure Notice from GST ...

Show Cause Notice

Disclosure Notice

Equity Shares Transfer to IEPF

New Newspaper Publication

Compliance Report Submission

Approval Received

Earnings Conference Call Tr...

Disclosure Notice

Financial Results Publication

Inspection Completion

Show Cause Notice

Certification Compliance

Compliance Certificate Subm...

Compliance Certificate

Corporate Guarantee Announc...

Cessation of Directors

Auditor Appointments

Grant of Stock Options

Equity Shares Allotted

Commercial Production Comme...

Land Acquisition

Commercial Production Comme...

Analyst/Investor Meet

Schedule of Analyst/Investo...

Guarantee for Subsidiary

Newspaper Publication

Appointment of Independent ...

Inspection closure

Earnings Conference Call

Compliance Certificate

Schedule of Analyst/ Instit...

Investor Conferences

Earnings Call Transcript

Unaudited Financial Results...

Related Party Transactions ...

Earnings Conference Call

USFDA Inspection

Issuance of Corporate Guara...

Earnings Conference Call

Compliance Certificate Subm...

Advertisement Publication

Resignation Announcement

Newspaper Advertisement

Fire Accident Update

Conference Meetings

Group meeting, One-on-One m...

Analyst/ Investor Meet

Financial Statements

Financial Statements

Equity, Debt, VC, Private E...

Earnings Guidance

Conference Call

Earnings Guidance

Major product launches or d...

Compliance Certificate

Analyst / Investor Meet

Earnings Guidance

Asset Acquisitions

Asset Acquisitions

Asset Acquisitions

Clearance on Remote Record ...

US FDA Inspection

Management Changes

Investor Meetings

Postal Ballot Notice Dispat...

Earnings Call Transcript

Code of Conduct adoption

Related Party Transactions ...

External Links:

Data:

Indoco Remedies Ltd. received final approval from the USFDA for its Abbreviated New Drug Application (ANDA) to market Varenicline Tablets, 0.5 mg and 1 mg, as a generic version of Chantix Tablet, aiding smoking cessation.

AI Assistant

Indoco Remedies Ltd

2024

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.